Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

53.48 +2.13 (+4.16%)

Streaming Delayed Price Updated: 1:46 PM EDT, Mar 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Top S&P500 movers in Thursday's session ↗

May 22, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session.

Via Chartmill

Moderna Stock Looks Ripe for a Short Squeeze

May 22, 2025

Moderna stock has made single-digit gains in the last month, and high short interest suggests that any bullish news could cause a short squeeze

Via MarketBeat

Topics Government

Moderna Reverses Its Rally As It Faces Another Vaccine Setback ↗

May 21, 2025

The company previously guided to a longer timeline for its Covid/flu shot. But Wednesday's news introduces some data risk.

Via Investor's Business Daily

Moderna Pulls Application For Seasonal Flu, Covid Combination Vaccine: But Retail Gets More Bullish ↗

May 21, 2025

Moderna will resubmit the application later this year after data from its ongoing late-stage trial of its seasonal flu vaccine is available.

Via Stocktwits

How Is The Market Feeling About Moderna? ↗

May 20, 2025

Via Benzinga

Hedge Funds Are Building A Towering Wall Of Bets Against Stocks ↗

May 21, 2025

After a sharp 23% rebound in the S&P 500 since April, hedge funds are now stacking record levels of bearish bets against stocks as investors question the staying power of the tariff-relief rally.

Via Benzinga

Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19

May 21, 2025

Via ACCESS Newswire

FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr. ↗

May 21, 2025

The U.S. Food and Drug Administration has announced significant changes to COVID-19 vaccine requirements, limiting annual booster approvals to older and high-risk Americans while implementing stricter...

Via Benzinga

What's Going On With Vaccine Stocks Today? ↗

May 20, 2025

Shares of Vaccine stocks are moving higher on Tuesday after documents from the U.S. Food and Drug Administration revealed that its advisers will meet this week.

Via Benzinga

What's going on in today's session: S&P500 movers ↗

May 20, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Stay informed about the most active stocks in the S&P500 index on Tuesday's session. ↗

May 20, 2025

Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention.

Via Chartmill

Moderna (MRNA) Stock Trades Up, Here Is Why

May 20, 2025

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 7% in the afternoon session after the FDA announced new regulatory guidelines that still allow quick COVID vaccine approvals for seniors and...

Via StockStory

Topics Government World Trade

FDA Sets New Guidelines For Approving COVID-19 Booster Shots In Healthy Individuals: Moderna, Novavax Stocks Rise ↗

May 20, 2025

The agency plans to demand stronger evidence of efficacy for the shots before approval is granted for healthy persons, between the ages of six months and 64 years, with no risk factors for severe...

Via Stocktwits

Exploring the top movers within the S&P500 index during today's session. ↗

May 20, 2025

Stay updated with the movements of the S&P500 index in the middle of the day on Tuesday. Discover which stocks are leading as top gainers and losers in today's session.

Via Chartmill

The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped. ↗

May 20, 2025

The new framework limits future Covid shots to people age 65 and older and those six months and older with a risk factor for serious illness.

Via Investor's Business Daily

Topics Bankruptcy Government

What's going on in today's session: S&P500 movers ↗

May 19, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Stocks Mixed, Treasury Bonds Slip On Moody's US Downgrade: What's Driving Markets Monday? ↗

May 19, 2025

U.S. stocks trimmed early-session losses by midday Monday, as investors showed limited concern after Moody's downgraded U.S. sovereign credit from Aaa to Aa1, effectively stripping the world's largest...

Via Benzinga

Topics Economy

Uncover the latest developments among S&P500 stocks in today's session. ↗

May 19, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Novavax Scores Key FDA Win, Shares Jump 19% As Sanofi Unlocks Milestone Payment ↗

May 19, 2025

Novavax's COVID-19 vaccine, Nuvaxovid™, receives limited FDA approval and triggers $175M milestone payment. Commercial distribution planned for fall.

Via Benzinga

Discover which S&P500 stocks are making waves on Friday. ↗

May 16, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Friday as we examine the latest happenings in today's session.

Via Chartmill

Explore the top gainers and losers within the S&P500 index in today's session. ↗

May 16, 2025

Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session.

Via Chartmill

1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid ↗

May 16, 2025

Via The Motley Fool

MRNA Q1 Earnings Call: Management Focuses on Cost Reductions and Pipeline Progress Amid Revenue Shortfall

May 14, 2025

Biotechnology company Moderna (NASDAQ:MRNA) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 35.3% year on year to $108 million. The company’s full-year revenue guidance of $2...

Via StockStory

Stay informed with the top movers within the S&P500 index on Wednesday. ↗

May 14, 2025

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.

Via Chartmill

What's going on in today's session: S&P500 movers ↗

May 14, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

Thermo Fisher, Biogen, Gilead Sciences, Moderna, and QuidelOrtho Stocks Trade Up, What You Need To Know

May 12, 2025

A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides...

Via StockStory

Topics Government Stocks World Trade

Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025

May 08, 2025

Via ACCESS Newswire

Top gainers and losers in the S&P500 index during Wednesday's after-hours session. ↗

May 07, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers.

Via Chartmill

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗

May 07, 2025

FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and analyst concerns.

Via Benzinga

Market Monitor May 7 ( Hims & Hers Health, Upwork UP - Palantir, Monderna DOWN) ↗

May 07, 2025

Markets slide on vaccine regulation fears, trade uncertainty, and cautious earnings despite strong tech and consumer stock moves.

Via Chartmill

< Previous 1 2

...

15 16 17 18 19 20 21 22 23

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.